MedTrace Logo

Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)

NCT02902445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 611

Last updated 2022-04-11

No results posted yet for this study

Summary

The GASTROVIM research explores the links between individual genetic susceptibility, genetic variability of rotavirus strains and effectiveness of immunization with the rotavirus vaccination: a clinical investigation to assess glycan attachment specificity, toward rotavirus vaccine improvement.

Conditions

Interventions

BIOLOGICAL

rotavirus rapid screen test

According to routine care

GENETIC

polymorphism exploration

from an oral swab collected after parents consent

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Christèle GRAS-LEGUEN, MD PhD · Nantes University Hospital

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2020-10-15
Completion
2020-10-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02902445 on ClinicalTrials.gov